1985
DOI: 10.1111/j.1432-0436.1985.tb00510.x
|View full text |Cite
|
Sign up to set email alerts
|

Vitiligo-related pigment cell differentiation antigens are expressed on malignant melanoma cells following phenotypic reversion induced by contact inhibitory factor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

1985
1985
2008
2008

Publication Types

Select...
4
1
1

Relationship

3
3

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 10 publications
0
3
0
Order By: Relevance
“…The earliest evidence that the melanoma malignant phenotype is reversible epigenetically was the finding that a ''contact-inhibitory factor'' present in culture medium of a revertant line of melanoma cells could restore in vitro growth control (contact-, serum-, and anchorage-dependent growth) to melanoma cells (Lipkin and Knecht, 1974;Lipkin et al, 1986), cause early G 1 growth arrest (Lipkin and Knecht, 1976), reorganize the actin cytoskeleton (Higgins et al, 1988), induce synthesis of pigment differentiation antigens (Lipkin et al, 1985), and upregulate class I major histocompatibility antigens (Lipkin and Meruelo, 1992), increasing lysis by cytotoxic (CD8) T lymphocytes (unpublished data). It also suppressed both angiogenesis (Lipkin et al, 2001) and metastasis (unpublished data), and led to permanent regression of tumors treated in situ (Lipkin et al, 1989).…”
Section: Melanoma Cell Plasticitymentioning
confidence: 99%
“…The earliest evidence that the melanoma malignant phenotype is reversible epigenetically was the finding that a ''contact-inhibitory factor'' present in culture medium of a revertant line of melanoma cells could restore in vitro growth control (contact-, serum-, and anchorage-dependent growth) to melanoma cells (Lipkin and Knecht, 1974;Lipkin et al, 1986), cause early G 1 growth arrest (Lipkin and Knecht, 1976), reorganize the actin cytoskeleton (Higgins et al, 1988), induce synthesis of pigment differentiation antigens (Lipkin et al, 1985), and upregulate class I major histocompatibility antigens (Lipkin and Meruelo, 1992), increasing lysis by cytotoxic (CD8) T lymphocytes (unpublished data). It also suppressed both angiogenesis (Lipkin et al, 2001) and metastasis (unpublished data), and led to permanent regression of tumors treated in situ (Lipkin et al, 1989).…”
Section: Melanoma Cell Plasticitymentioning
confidence: 99%
“…More recently, we have found in collaboration with Drs. G. Lipkin and M. Rosenberg, at the NYU Medical Center, that vitiligo antigens can be induced in nonpigmented hamster melanoma cells by treatment with a factor which causes them to differentiate towards a normal phenotype (26), even though they remain depigmented. This observation suggests that the vitiligo antigens are markers for the terminal differentiation of melanocytes.…”
Section: Characterization Ofvitiligo Antigenmentioning
confidence: 99%
“…CIF, a diffusible substance found in the conditioned medium of revertant (contact-inhibited) hamster melanocytic cells (Lipkin and Knecht, 1974), mediates certain changes in morphology, growth and differentiation of various cultured tumor cells. Such alterations include: (a) restoration of contact inhibition, (b) regain of anchorage-and serum-dependent proliferation, (c) induction of pigment-cell differentiation antigens on mouse and hamster melanoma cells, and (d) reduced susceptibility of human melanoma, colon carcinoma, and erythroleukemia cells to lysis by NK cells Knecht, 1974, 1976;Lipkin et al, 1978Lipkin et al, , 1985Lipkin et al, , 1986Nabi et al., 1986). CIF reduces cell proliferation by initiating a GI arrest, or at least a prolongation of this cell-cycle phase (Lipkin and Knecht, 1976).…”
mentioning
confidence: 99%